Estimate of Radiobiologic Parameters From Clinical Data for Biologically Based Treatment Planning for Liver Irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 3, 2008, Pages 900-907

  Tai, An ^a   Erickson, Beth ^a   Khater, Kevin A ^a   Li, X Allen ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Hypofractionation; Lyman model; Radiobiologic parameter; Survival rate

Indexed keywords

DOSIMETRY; FRACTIONATION; LIVER; ONCOLOGY; TUMORS;

HYPOFRACTIONATION; LYMAN MODEL; RADIOBIOLOGIC PARAMETERS; RADIOSENSITIVITY PARAMETERS; SURVIVAL RATE;

RADIOTHERAPY;

ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; HUMAN; IRRADIATION; LIVER CELL CARCINOMA; LIVER IRRADIATION; LIVER TUMOR; LIVER WEIGHT; PARAMETER; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; TREATMENT PLANNING;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; DOSE FRACTIONATION; HUMANS; LIVER; LIVER NEOPLASMS; MODELS, BIOLOGICAL; RADIOBIOLOGY; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; SURVIVAL RATE;

EID: 38849119784     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.10.037     Document Type: Article

References (38)

1. Ben-Josef E., and Lawrence T.S. Radiotherapy for unresectable hepatic malignancies. Semin Radiat Oncol 15 (2005) 273-278
2. Tsuzuki T., Sugioka A., and Ueda M. Hepatic resection for hepatocellular carcinoma. Surgery 107 (1990) 511-520
3. Nagorney D.M., van Heerden J.A., Ilstrup D.M., et al. Primary hepatic malignancy: Surgical management and determinants of survival. Surgery 1067 (1989) 740-748
4. Hashimoto T., Tokuuye K., Fukumitsu N., et al. Repeated proton therapy for hepatocellular carcinoma. J Radiat Oncol Biol Phys 65 (2006) 196-202
5. Ben-Josef E., Normolle D., Ensminger W.D., et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridline for unresectable intrahepatic malignancies. J Clin Oncol 23 (2005) 8739-8747
6. Seong J., Park H.C., Han K.H., and Chon C.Y. Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients. J Radiat Oncol Biol Phys 55 (2003) 329-336
7. Wu D.H., Liu L., and Chen L.H. Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 10 (2004) 2184-2189
8. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic maglignancies. J Clin Oncol 18 (2000) 2210-2218
9. Hawkins M.A., and Dawson L.A. Radiation therapy for hepatocellular carcinoma from palliation to cure. Cancer 106 (2006) 1653-1663
10. Liang S.X., Zhu X.D., Lu H.J., et al. Hypofractionated three-dimendional conformal radiation therapy for primary liver carcinoma. Cancer 103 (2005) 2181-2188
11. Liu M.T., Li S.H., Chu T.C., et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol 34 (2004) 532-539
12. Guo W.J., and Yu E.X. Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma. Br J Radiol 73 (2000) 1091-1097
13. Nakagawa K., Yamashita H., Shiraishi K., et al. Radiation therapy for portal venous invasion by hepatocellular carcinoma. World J Gastroenterol 11 (2005) 7237-7241
14. Cheng J.C., Chuang V.P., Cheng S.H., et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. J Radiat Oncol Biol Phys 47 (2000) 435-442
15. Herfarth K.K., Debus J., Lohr F., et al. Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I//II trial. J Clin Oncol 19 (2001) 164-170
16. Kim T.H., Kim D.Y., Park J.W., et al. Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable. Am J Clin Oncol 29 (2006) 568-575
17. Mornex F., Girard N., Beziat C., et al. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French phase II RTF-1 trial. Int J Radiat Oncol Biol Phys 66 (2006) 1152-1158
18. Katz AW, Dawson LA, Elsaleh H, et al. A phase I trial of highly conformal radiation therapy for patients with liver metastases. Radiation Therapy Oncology Group 0438. Accessed at http://www.rtog.org.
19. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. J Radiat Oncol Biol Phys 53 (2002) 810-821
20. Xu ZY, Liang SX, Zhu J RD et al. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformation radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 2006;65:189-195.
21. Sachs R.K., Hahnfeldt P., and Brenner D.J. The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int J Radiat Biol 72 (1997) 351-374
22. Qi X.R., Schultz C.J., and Li X.A. An estimation of radiobiological parameters from clinical outcomes for radiation treatment planning of brain tumors. Int J Radiat Oncol Biol Phys 64 (2006) 1570-1580
23. Webb S., and Nahum A.E. A model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 38 (1993) 653-666
24. Mathew A., Pandey M., and Murthy N.S. Survival analysis: Caveats and pitfalls. Eur J Surg Oncol 25 (1999) 321-329
25. Stavrev P., Hristov D., Field C., et al. Fractionation correction to Lyman's model. Med Phys 29 (2002) 1248-1248
26. Fertil B., and Malaise E.P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11 (1985) 1699-1707
27. Deacon J.M., Peckham M.J., and Steel G.G. The radioresponsiveness of human tumors and the initial slope of the cell survival curve. J Radiother Oncol 2 (1984) 317-323
28. Ruiz de Almodovar J.M., Nunez M.I., McMillan T.J., et al. Initial radiation-induced DNA damage in human tumor cell lines: A correlation with intrinsic cellular radiosensitivity. Br J Cancer 69 (1994) 457-462
29. Brenner D.J. Dose, volume, and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 26 (1993) 171-179
30. Webb S. Optimum parameters in a model of tumor control probability including interpatient heterogeneity. Phys Med Biol 39 (1994) 1895-1914
31. Wang J.Z., Stewart R.D., Carlson D.J., et al. Comments on the "Comparison of in vitro and in vivo α/β ratios for prostate cancer." In response to Drs. Daşu and Fowler. Phys Med Biol 50 (2005) L5-L8
32. Fowler J.F., and Chappell R.J. Ritter MA Is α/β for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
33. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
34. Dasu A., and Fowler J.F. Comments on the "Comparison of in vitro and in vivo α/β ratios for prostate cancer.". Phys Med Biol 50 (2005) L1-L4
35. Cucchetti A., Vivarelli M., Piscaglia F., et al. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis. J Hepatol 43 (2005) 310-316
36. Sheu J.C., Sung J.L., Chen D.S., et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implication. Gastroenterology 89 (1985) 259-266
37. Speer J., Petrosky V., Retsky M., et al. A stochastic numerical model of breast cancer growth that simulates clinical data. Cancer Res 44 (1984) 4124-4130
38. Dawson L.A., Eccles C., and Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 45 (2006) 856-864